Jens Mikkelsen
SCIENTIFIC ADVISOR
Bionomics
Australia
Biography
Dr Mikkelsen is a translational neuroscientist. He received his Medical Degree in 1986 from the University of Copehagen and after post-doctoral training in Denmark, UK and USA, he established a neuroscience research laboratory at the University of Copenhagen studying the circadian timing system. Since 1995, he spend 16 years in the pharmacrutical industry and key positions include Head of Neurobiology, H.Lundbeck, Director of Pharmacology, Zealand Pharma, CSO/CEO, Azign Bioscience, and Head of Translational Neuroscience, NeuroSearch. In these roled Dr Mikkelsen has been instrumental in target selection and target validation, and bringing early stage products to clinical testing. Examples include drugs for obesity, diabetes, depression, Alzheimer's disease, dyskinesia, and schizophrenia, some of which have been successful in late clinical trials entered into NDA. Dr Mikkelsen has also worked as group leader of the translational neuropharmacology group at the Univerity Hospital in Copenhagen, aimed at understanding the mechanism of action of CNS drugs, with special attention on cognitive enhancers. Dr Mikkelsen has published more than 250 original papers in the fields of neuroscience and pharmacology, and has been the inventor of a number of patents.
Research Interest
Research interest on Business Development
